Why is melanoma so metastatic?
暂无分享,去创建一个
[1] G. Stamp,et al. Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma , 2013, The Journal of pathology.
[2] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[3] A. Weeraratna,et al. A Wnt-er Migration: The Confusing Role of β-Catenin in Melanoma Metastasis , 2013, Science Signaling.
[4] Dean Y. Li,et al. The Small GTPase ARF6 Stimulates β-Catenin Transcriptional Activity During WNT5A-Mediated Melanoma Invasion and Metastasis , 2013, Science Signaling.
[5] Oshin Vartanian,et al. Lesions to right prefrontal cortex impair real-world planning through prematurecommitments , 2013, Neuropsychologia.
[6] K. Flaherty,et al. Elucidating distinct roles for NF1 in melanomagenesis. , 2013, Cancer discovery.
[7] L. Chin,et al. HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome , 2013, Oncogene.
[8] M. Aurrand-Lions,et al. Soluble Melanoma Cell Adhesion Molecule (sMCAM/sCD146) Promotes Angiogenic Effects on Endothelial Progenitor Cells through Angiomotin* , 2013, The Journal of Biological Chemistry.
[9] R. Sullivan,et al. BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma , 2013, Clinical Cancer Research.
[10] Matthew J. Davis,et al. RAC1P29S is a spontaneously activating cancer-associated GTPase , 2013, Proceedings of the National Academy of Sciences.
[11] M. Millward,et al. Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression , 2013, The British journal of dermatology.
[12] A. Jemal,et al. Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.
[13] D. McConkey,et al. Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin. , 2012, Cancer research.
[14] S. Morrison,et al. Human Melanoma Metastasis in NSG Mice Correlates with Clinical Outcome in Patients , 2012, Science Translational Medicine.
[15] Peter J. Campbell,et al. Evolution of the cancer genome , 2012, Nature Reviews Genetics.
[16] A. Vartanian. RETRACTED ARTICLE: Signaling pathways in tumor vasculogenic mimicry , 2012, Biochemistry (Moscow).
[17] F. Passarelli,et al. Expression of vascular endothelial growth factor‐C in primary cutaneous melanoma predicts sentinel lymph node positivity , 2012, Journal of cutaneous pathology.
[18] M. Bar‐eli,et al. The sweet and bitter sides of galectins in melanoma progression , 2012, Pigment cell & melanoma research.
[19] P. Kulesa,et al. Melanoma revives an embryonic migration program to promote plasticity and invasion , 2012, Pigment cell & melanoma research.
[20] Qiao Li,et al. Tumor cell-derived exosomes: a message in a bottle. , 2012, Biochimica et biophysica acta.
[21] A. Sivachenko,et al. A Landscape of Driver Mutations in Melanoma , 2012, Cell.
[22] Matthew J. Davis,et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma , 2012, Nature Genetics.
[23] Timothy J. Lavelle,et al. Understanding the Melanocyte Distribution in Human Epidermis: An Agent-Based Computational Model Approach , 2012, PloS one.
[24] David C. Smith,et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.
[25] M. Bar‐eli,et al. Driving transcriptional regulators in melanoma metastasis , 2012, Cancer and Metastasis Reviews.
[26] Gema Moreno-Bueno,et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.
[27] J. Wolchok,et al. Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial. , 2012, The Lancet. Oncology.
[28] G. Mills,et al. Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells. , 2012, The American journal of pathology.
[29] H. Moch,et al. Tumor Cell Plasticity and Angiogenesis in Human Melanomas , 2012, PloS one.
[30] T. Fennell,et al. Melanoma genome sequencing reveals frequent PREX2 mutations , 2012, Nature.
[31] D. Morton,et al. Surgery for distant melanoma metastasis. , 2012, Cancer journal.
[32] J. Wolchok,et al. Targeting immune checkpoints: releasing the restraints on anti-tumor immunity for patients with melanoma. , 2012, Cancer journal.
[33] C. V. Jongeneel,et al. Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma , 2011, Nature Genetics.
[34] J. Wilmott,et al. Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma , 2011, Clinical Cancer Research.
[35] R. Gibbs,et al. Frequent somatic MAP3K5 and MAP3K9 mutations in metastatic melanoma identified by exome sequencing , 2011, Nature Genetics.
[36] H. Woo,et al. Cross-species hybridization of microarrays for studying tumor transcriptome of brain metastasis , 2011, Proceedings of the National Academy of Sciences.
[37] E. Greanya,et al. The role of hepatitis B immunoglobulin in hepatitis B related liver transplantation: Canadian Transplant Centre Position Paper. , 2011, Annals of hepatology.
[38] Yibin Kang,et al. Unravelling the complexity of metastasis — molecular understanding and targeted therapies , 2011, Nature Reviews Cancer.
[39] Gerald C. Chu,et al. Proinvasion metastasis drivers in early-stage melanoma are oncogenes. , 2011, Cancer cell.
[40] Axel Hoos,et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. , 2011, The New England journal of medicine.
[41] I. Fidler,et al. The seed and soil hypothesis revisited—The role of tumor‐stroma interactions in metastasis to different organs , 2011, International journal of cancer.
[42] S. Wickline,et al. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. , 2011, Cancer research.
[43] M. Bar‐eli,et al. Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression. , 2011, Cancer research.
[44] S. Davis,et al. Exome sequencing identifies GRIN2A as frequently mutated in melanoma , 2011, Nature Genetics.
[45] H. Moch,et al. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. , 2011, Cancer research.
[46] M. Bar‐eli,et al. Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment. , 2011, Seminars in cancer biology.
[47] D. Lyden,et al. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. , 2011, Seminars in cancer biology.
[48] T. van Hall,et al. Strategies to counteract MHC-I defects in tumors. , 2011, Current opinion in immunology.
[49] Kylie M. Price,et al. Murine Melanoma-Infiltrating Dendritic Cells Are Defective in Antigen Presenting Function Regardless of the Presence of CD4+CD25+ Regulatory T Cells , 2011, PloS one.
[50] Sean Davis,et al. Interferon-γ links ultraviolet radiation to melanomagenesis in mice. , 2011, Nature.
[51] M. Bar‐eli,et al. Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype , 2010, Proceedings of the National Academy of Sciences.
[52] A. Bowcock,et al. Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas , 2010, Science.
[53] K. Hoek,et al. Cancer stem cells versus phenotype‐switching in melanoma , 2010, Pigment cell & melanoma research.
[54] J. O'Brien,et al. Mutations in GNA11 in uveal melanoma. , 2010, The New England journal of medicine.
[55] P. Courtoy,et al. A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice. , 2010, Cancer research.
[56] K. Aldape,et al. Reactive astrocytes protect melanoma cells from chemotherapy by sequestering intracellular calcium through gap junction communication channels. , 2010, Neoplasia.
[57] M. Bar‐eli,et al. CREB Inhibits AP-2α Expression to Regulate the Malignant Phenotype of Melanoma , 2010, PloS one.
[58] V. Engelhard,et al. Tumor masses support naive T cell infiltration, activation, and differentiation into effectors , 2010, The Journal of experimental medicine.
[59] A. Dalgleish,et al. T regulatory cells, the evolution of targeted immunotherapy. , 2010, Biochimica et biophysica acta.
[60] F. Garrido,et al. “Hard” and “soft” lesions underlying the HLA class I alterations in cancer cells: Implications for immunotherapy , 2010, International journal of cancer.
[61] D. Fisher,et al. How Sunlight Causes Melanoma , 2010, Current oncology reports.
[62] K. Flaherty,et al. Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function. , 2010, Cancer research.
[63] Gary D Bader,et al. International network of cancer genome projects , 2010, Nature.
[64] D. Roberts,et al. Autotaxin Signaling via Lysophosphatidic Acid Receptors Contributes to Vascular Endothelial Growth Factor–Induced Endothelial Cell Migration , 2010, Molecular Cancer Research.
[65] Djuro Josic,et al. Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription. , 2010, Experimental hematology.
[66] Jeffrey E Gershenwald,et al. Final version of 2009 AJCC melanoma staging and classification. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[67] W. Sellers,et al. MEK1 mutations confer resistance to MEK and B-RAF inhibition , 2009, Proceedings of the National Academy of Sciences.
[68] D. Schadendorf,et al. Skin Melanoma Development in ret Transgenic Mice Despite the Depletion of CD25+Foxp3+ Regulatory T Cells in Lymphoid Organs1 , 2009, The Journal of Immunology.
[69] M. Hung,et al. Crosstalk between Protease-activated Receptor 1 and Platelet-activating Factor Receptor Regulates Melanoma Cell Adhesion Molecule (MCAM/MUC18) Expression and Melanoma Metastasis* , 2009, The Journal of Biological Chemistry.
[70] M. Bar‐eli,et al. Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43. , 2009, Cancer research.
[71] M. Bar‐eli,et al. Silencing cAMP-response Element-binding Protein (CREB) Identifies CYR61 as a Tumor Suppressor Gene in Melanoma* , 2009, The Journal of Biological Chemistry.
[72] M. Bar‐eli,et al. Inflammation and melanoma metastasis , 2009, Pigment cell & melanoma research.
[73] J. Pollard,et al. Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.
[74] Jacopo Meldolesi,et al. Shedding microvesicles: artefacts no more. , 2009, Trends in cell biology.
[75] Rakesh K. Singh,et al. Host CXCR2-dependent regulation of melanoma growth, angiogenesis, and experimental lung metastasis. , 2009, Cancer research.
[76] E. Simpson,et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue nevi , 2008, Nature.
[77] M. Bar‐eli,et al. Tumorigenesis and Neoplastic Progression Expression Profiling of Galectin-3-Depleted Melanoma Cells Reveals Its Major Role in Melanoma Cell Plasticity and Vasculogenic Mimicry , 2010 .
[78] R. Moon,et al. CTLA-4 is a direct target of Wnt/beta-catenin signaling and is expressed in human melanoma tumors. , 2008, The Journal of investigative dermatology.
[79] A. Sood,et al. Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA. , 2008, Cancer research.
[80] S. Morrison,et al. Efficient tumor formation by single human melanoma cells , 2008, Nature.
[81] L. Ellis,et al. VEGF-targeted therapy: mechanisms of anti-tumour activity , 2008, Nature Reviews Cancer.
[82] George Poste,et al. The "seed and soil" hypothesis revisited. , 2008, The Lancet. Oncology.
[83] J. Kirkwood,et al. Next generation of immunotherapy for melanoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[84] M. Bar‐eli,et al. Transcriptional control of the melanoma malignant phenotype , 2008, Cancer biology & therapy.
[85] F. Garrido,et al. Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy , 2008, Immunogenetics.
[86] T. Nomura,et al. Regulatory T Cells and Immune Tolerance , 2008, Cell.
[87] J. Schalkwijk,et al. Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule. , 2008, Cancer research.
[88] G. Zhu,et al. B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells. , 2008, Blood.
[89] Kylie M. Price,et al. Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells , 2008, Cancer Immunology, Immunotherapy.
[90] S. Ofori-Acquah,et al. Activated leukocyte cell adhesion molecule: a new paradox in cancer. , 2008, Translational research : the journal of laboratory and clinical medicine.
[91] C. Hess,et al. Polymorphonuclear Neutrophil-Derived Ectosomes Interfere with the Maturation of Monocyte-Derived Dendritic Cells1 , 2008, The Journal of Immunology.
[92] M. Bar‐eli,et al. Inflammation and melanoma growth and metastasis: The role of platelet-activating factor (PAF) and its receptor , 2007, Cancer and Metastasis Reviews.
[93] Kenneth P. Roos,et al. Autocrine VEGF Signaling Is Required for Vascular Homeostasis , 2007, Cell.
[94] J. McNamara. Cancer Stem Cells , 2007, Methods in Molecular Biology.
[95] A. Rudensky,et al. TGFβ signalling in control of T-cell-mediated self-reactivity , 2007, Nature Reviews Immunology.
[96] Arie Perry,et al. Transcriptomic versus Chromosomal Prognostic Markers and Clinical Outcome in Uveal Melanoma , 2007, Clinical Cancer Research.
[97] J. Gershenwald,et al. Galectin-3 Expression Is Associated with Tumor Progression and Pattern of Sun Exposure in Melanoma , 2006, Clinical Cancer Research.
[98] M. Bar‐eli,et al. Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8. , 2006, Pigment cell research.
[99] Z. Trajanoski,et al. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.
[100] J Ratajczak,et al. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication , 2006, Leukemia.
[101] Y. Kawakami,et al. The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells , 2006, The Journal of experimental medicine.
[102] Colgan P. Sean. Cell-Cell Interactions , 2006, Methods in Molecular Biology™.
[103] Richard A Flavell,et al. Transforming growth factor-beta regulation of immune responses. , 2006, Annual review of immunology.
[104] Rakesh K. Singh,et al. Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma. , 2006, American journal of clinical pathology.
[105] S. Rafii,et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.
[106] Jean-Philippe Brunet,et al. The melanocyte differentiation program predisposes to metastasis after neoplastic transformation , 2005, Nature Genetics.
[107] N. Chen,et al. Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway. , 2005, Molecular biology of the cell.
[108] M. Herlyn,et al. Adhesion, migration and communication in melanocytes and melanoma. , 2005, Pigment cell research.
[109] G. Swart,et al. Activated leukocyte cell adhesion molecule (ALCAM/CD166): Signaling at the divide of melanoma cell clustering and cell migration? , 2005, Cancer and Metastasis Reviews.
[110] Gerard C Blobe,et al. Role of transforming growth factor Beta in human cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[111] G. Raposo,et al. Exosomes: endosomal-derived vesicles shipping extracellular messages. , 2004, Current opinion in cell biology.
[112] T. Utsugi,et al. CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells. , 2003, Immunity.
[113] M. Barbacid,et al. RAS oncogenes: the first 30 years , 2003, Nature Reviews Cancer.
[114] Michelle L. Varney,et al. IL-8 Directly Enhanced Endothelial Cell Survival, Proliferation, and Matrix Metalloproteinases Production and Regulated Angiogenesis1 , 2003, The Journal of Immunology.
[115] Hisataka Kobayashi,et al. Inflammatory breast cancer: Vasculogenic mimicry and its hemodynamics of an inflammatory breast cancer xenograft model , 2003, Breast Cancer Research.
[116] Kim-Anh Do,et al. Steps toward mapping the human vasculature by phage display , 2002, Nature Medicine.
[117] Suyun Huang,et al. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma. , 2002, Cancer research.
[118] M. Schachner,et al. Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma. , 2002, European journal of cancer.
[119] D. Lev,et al. Cellular Adhesion Pathways and Metastatic Potential of Human Melanoma , 2002, Cancer biology & therapy.
[120] Haidong Dong,et al. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion , 2002, Nature Medicine.
[121] Laurence Zitvogel,et al. Exosomes: composition, biogenesis and function , 2002, Nature Reviews Immunology.
[122] S. Ullrich,et al. Platelet-activating Factor, a Molecular Sensor for Cellular Damage, Activates Systemic Immune Suppression , 2002, The Journal of experimental medicine.
[123] R. Tampé,et al. Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway. , 2001, Cancer research.
[124] A. Montgomery,et al. Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells. , 2001, Molecular biology of the cell.
[125] Paul S. Meltzer,et al. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: Role in vasculogenic mimicry , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[126] Jeffrey E Gershenwald,et al. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo , 2001, Oncogene.
[127] K Satyamoorthy,et al. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. , 2001, Cancer research.
[128] Z. Ronai,et al. Activating transcription factor 2-derived peptides alter resistance of human tumor cell lines to ultraviolet irradiation and chemical treatment. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[129] H. Hall,et al. CD4+CD25+ regulatory T cells down‐regulate co‐stimulatory molecules on antigen‐presenting cells , 2000, European journal of immunology.
[130] J. J. van den Oord,et al. Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin. , 2000, The American journal of pathology.
[131] G. Parmiani,et al. T‐cell recognition of melanoma‐associated antigens , 2000 .
[132] P. Meltzer,et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. , 1999, The American journal of pathology.
[133] M. Herlyn,et al. Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions , 1999, International journal of cancer.
[134] M. Bar‐eli. Role of Interleukin-8 in Tumor Growth and Metastasis of Human Melanoma , 1999, Pathobiology.
[135] V. Kosma,et al. Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[136] E. Voura,et al. Cell–cell interactions during transendothelial migration of tumor cells , 1998, Microscopy research and technique.
[137] D. Williams,et al. Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. , 1998, Journal of immunology.
[138] R. Frade,et al. Procathepsin-L, a proteinase that cleaves human C3 (the third component of complement), confers high tumorigenic and metastatic properties to human melanoma cells. , 1998, Cancer research.
[139] P. Heikkilä,et al. Enhanced expression of vascular endothelial growth factor in metastatic melanoma. , 1997, British Journal of Cancer.
[140] D J Ruiter,et al. Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis , 1997, Melanoma research.
[141] J. Johnson,et al. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. , 1997, Cancer research.
[142] A. Vitiello,et al. Expression and regulation of the neural cell adhesion molecule L1 on human cells of myelomonocytic and lymphoid origin. , 1997, Journal of immunology.
[143] M. Schachner,et al. L1/HNK‐1 Carbohydrate‐ and β1 Integrin‐Dependent Neural Cell Adhesion to Laminin‐1 , 1997, Journal of neurochemistry.
[144] M. Hortsch,et al. The L1 Family of Neural Cell Adhesion Molecules: Old Proteins Performing New Tricks , 1996, Neuron.
[145] M. Herlyn,et al. Shifts in cadherin profiles between human normal melanocytes and melanomas. , 1996, The journal of investigative dermatology. Symposium proceedings.
[146] M. Mihm,et al. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma , 1996, Cancer.
[147] J. Becker,et al. Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3 , 1996, The Journal of cell biology.
[148] R. Frade,et al. A cysteine proteinase, which cleaves human C3, the third component of complement, is involved in tumorigenicity and metastasis of human melanoma. , 1996, Cancer research.
[149] M. Lipkind,et al. Isolation of Yucaipa virus , 1995, Veterinary Record.
[150] R. Dermietzel,et al. Immunolocalization of the neural cell adhesion molecule L1 in non-proliferating epithelial cells of the male urogenital tract , 1995, Histochemistry and Cell Biology.
[151] D. Elder,et al. Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes. , 1994, The American journal of pathology.
[152] R. Folberg,et al. Microcirculation architecture of melanocytic nevi and malignant melanomas of the ciliary body and choroid. A comparative histopathologic and ultrastructural study. , 1994, Ophthalmology.
[153] W. Westerhof,et al. Organotypic culture of human skin to study melanocyte migration. , 1994, Pigment cell research.
[154] N. S. Mcnutt,et al. Differential expression of basic fibroblast growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. Implications for tumor progression. , 1994, The American journal of pathology.
[155] H. Tsou,et al. Cultured human melanocytes express the intermediate filament vimentin. , 1993, The Journal of investigative dermatology.
[156] I. Shih,et al. Undifferentiated keratinocytes control growth, morphology, and antigen expression of normal melanocytes through cell-cell contact. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[157] A. Harris,et al. A study of adhesion molecules as markers of progression in malignant melanoma , 1992, The Journal of pathology.
[158] P. Altevogt,et al. Expression and function of the neural cell adhesion molecule L1 in mouse leukocytes , 1992, European journal of immunology.
[159] L. Liotta,et al. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. , 1992, The Journal of biological chemistry.
[160] A. Haake,et al. Keratinocytes regulate melanocyte number in human fetal and neonatal skin equivalents. , 1991, The Journal of investigative dermatology.
[161] H. Soyer,et al. Expression of Cytoskeletal Components in Melanocytic Skin Lesions An Immunohistochemical Study , 1991, The American Journal of dermatopathology.
[162] N. Bornfeld,et al. Nonrandom chromosomal abnormalities in primary uveal melanoma. , 1990, Journal of the National Cancer Institute.
[163] R. Rees,et al. Cytogenetic findings in six posterior uveal melanomas: Involvement of chromosomes 3, 6, and 8 , 1990, Genes, chromosomes & cancer.
[164] J. Rootman,et al. Monosomy 3 and isochromosome 8q in a uveal melanoma. , 1990, Cancer genetics and cytogenetics.
[165] R. Meli,et al. Isolation and identification of platelet-activating factor in UV-irradiated guinea pig skin. , 1988, Journal of pharmacological methods.
[166] J. Lehmann,et al. Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000. , 1987, Cancer research.
[167] H. Dvorak. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.
[168] S Paget,et al. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .
[169] Matthew J. Davis,et al. Exome sequencing identifies recurrent somatic RAC 1 mutations in melanoma , 2016 .
[170] Sophia Kluge,et al. Hard And Soft , 2016 .
[171] C. Figdor,et al. Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy? , 2012, The Lancet. Oncology.
[172] G. Barsh,et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi , 2010 .
[173] Mark Shackleton,et al. Efficient tumour formation by single human melanoma cells , 2008 .
[174] A. Rudensky,et al. TGFbeta signalling in control of T-cell-mediated self-reactivity. , 2007, Nature reviews. Immunology.
[175] Gabriel A. Rabinovich,et al. Galectins as modulators of tumour progression , 2005, Nature Reviews Cancer.
[176] K. Naresh,et al. Altered melanoma cell surface glycosylation mediates organ specific adhesion and metastasis via lectin receptors on the lung vascular endothelium , 2005, Clinical & Experimental Metastasis.
[177] Ridgway Pf. Tumours : wounds that do not heal. , 2002 .
[178] G. Zhu,et al. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion , 2002, Nature Medicine.
[179] G. Parmiani,et al. T-cell recognition of melanoma-associated antigens. , 2000, Journal of cellular physiology.
[180] E. Voura,et al. Role of cadherins in the transendothelial migration of melanoma cells in culture. , 1997, Cell motility and the cytoskeleton.
[181] D. Adams,et al. Cellular Adhesion , 1994, New Horizons in Therapeutics.
[182] S. Ferrone,et al. Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression. , 1991, The Journal of clinical investigation.
[183] M. Luck,et al. Genome sequencing , 1987, Nature.
[184] A. Haddow. Molecular repair, wound healing, and carcinogenesis: tumor production a possible overhealing? , 1972, Advances in cancer research.
[185] A. Vartanian. Signaling Pathways in Tumor Vasculogenic Mimicry , 2022 .
[186] Sozen,et al. Mutations in GNA 11 in Uveal Melanoma , 2022 .